HR_D

(VRTX) Vertex - Upside potential ahead of Earnings release

Long
HR_D Mis à jour   
NASDAQ:VRTX   Vertex Pharmaceuticals Incorporated
Vertex is now at levels close to those of Dec'19. Meanwhile, revenues increased +60% QoQ for Q3 2020 and EPS increased + 20% (also QoQ for Q3 2020). Operational cashflows have improved as well. If expected annual earnings are confirmed, Vertex confirms its upside potential and has also a positive outlook ahead as a result of the current environment.
Trade fermée: ordre d’arrêt atteint:
Thanks for your thumbs up on the idea. The stock hit my stop loss and thus I am out for the moment. VRTX reported Q4'2020 EPS of $2.51, missing the of $2.65 target - this is leading a downward drift. As pointed before, my thesis was yet to be confirmed by earnings release. Despite all this, earnings rose 47.6% YoY for VRTX. Thus, I still believe this is a great company to invest but I cannot see at which point it will (potentially) revert. Im waiting to enter again at a better stage (maybe 197-202 range?).
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.